483 University of Texas Southwestern Medical Center Nov 2018

483 University of Texas Southwestern Medical Center Nov 2018

Jason Caballero FDA, Reba Gates FDA$119.00 - Available Now

FDA investigators audited the University of Texas Southwestern Medical Center - Dallas, TX, United States facility and issued inspectional observations (via FDA 483) on 09 Nov 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 09 Nov 2018
  • Location: Dallas, United States
  • FEI: 3012367823
Add To Cart